Dermatology patient-derived health utility of facial angiofibroma associated with tuberous sclerosis complex
Jessie T. Lu, David K. E. Chan, Grace X. Li, Sophy T. F. Shih, Deshan F. Sebaratnam · 2026
Read Dermatology patient-derived health utility of facial angiofibroma associated with tuberous sclerosis complex by Jessie T. Lu, David K. E. Chan, Grace X. Li, Sophy T. F. Shih, Deshan F. Sebaratnam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424800.txt.
Description
Lu and colleagues measure in 2026 how much facial angiofibroma, the small red growths on the face caused by tuberous sclerosis complex, lowers quality of life. No one had previously converted that burden into a health utility, the number economists use to value health states.
Interviewers asked 100 dermatology patients to imagine living with almost-clear and with moderate facial growths, alongside blindness in one or both eyes for comparison, and valued each state three ways. Moderate growths scored clearly worse than almost-clear ones on every method. On average, participants said they would give up about 12 percent of their remaining life to be cured of moderate growths. That meant roughly seven of 57 years, or accepting a nine percent risk of immediate death. The authors argue that shrinking these growths can deliver real quality-of-life gains.
Catalog record
| CREATOR | Jessie T. Lu, David K. E. Chan, Grace X. Li, Sophy T. F. Shih, Deshan F. Sebaratnam |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |